Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06687161 · ClinicalTrials.gov registry record · NA

Treating Insomnia in Mild Cognitive Impairment

A NA study of Insomnia and Mild Cognitive Impairment (MCI), sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06687161 is a NA study of Insomnia and Mild Cognitive Impairment (MCI) that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 30 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06687161, a NA study of Insomnia and Mild Cognitive Impairment (MCI), is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS) therapy
  • BEHAVIORAL Cognitive behavioral therapy for insomnia (CBT-I)

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-05-01
Est. Completion 2028-06-30
Phase NA

What the Registry Record Tells You About NCT06687161

The ClinicalTrials.gov registry entry for NCT06687161 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) therapy is the first listed.

NCT06687161 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06687161 about?

NCT06687161 is a clinical study titled "Treating Insomnia in Mild Cognitive Impairment". The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy fo...

What is the current status of trial NCT06687161?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-01. Estimated completion is 2028-06-30.

What conditions does trial NCT06687161 study?

This clinical trial studies the following conditions: Insomnia, Mild Cognitive Impairment (MCI).

What interventions are being tested in trial NCT06687161?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) therapy (DEVICE), Cognitive behavioral therapy for insomnia (CBT-I) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06687161?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06687161 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.